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Background: Few reports document late outcomes in patients with decreased left ventricular function undergoing mitral valve repair (MVr). This 
study evaluates survival, clinical and echocardiographic outcomes in such patients (pts).
Methods: From 1/1993-6/2007, 193 pts with severe mitral regurgitation and ejection fraction (EF) <50% underwent MVr without CABG. A 
full sternotomy was utilized in 56 patients and a mini-thoracotomy (MT) in 137 patients. Mean age was 63.7 years (range 24-90 years). Mean 
preoperative NYHA Class was 2.8 (54.4% of pts were Class III or IV) and 41 (21.2%) pts had previous cardiac surgery. Preoperative EF was 40%-49% 
in 52 pts (26.9%), 30%-39% in 81 pts (42.0%), 20%-29% in 37 pts (19.2%), and <20% in 23 pts (11.9%). All pts were followed prospectively and 
late clinical follow-up was available at a mean interval of 41 months (range 0-163 months). Propensity balancing score was employed to examine 
the impact of surgical approach.
Results: Hospital mortality was 5.7% (11/193) overall; 3.6% (5/137) for MT. Propensity adjusted multivariate predictors (odds ratio; p-value) 
of hospital mortality were ischemic etiology (22.7; p=0.03), older age (p=0.04) and COPD (6.5; 0.03). Sternotomy approach (4.8; p=0 .10) and 
peripheral vascular disease (5.8; p=0.10) were weakly associated with hospital mortality. Overall survival was 74% at 5 years (84% for non-ischemic 
etiology pts and 51% for ischemic etiology pts (p<0.001). Multivariate predictors of decreased survival were advanced age (p<0.001), severely 
impaired EF (p=0.01), ischemic etiology (p<0.04), and cerebral vascular disease (p=0.06). NYHA class improved a mean of 0.9 grades (p=0.01). At 
five years freedom from valve reoperation was 92% and freedom from valve reoperation or severe recurrent mitral insufficiency was 88%.
Conclusions: MVr in patients with decreased ventricular function improves late NYHA functional status and is associated with good late survival. 
The predictors of poor survival are age, lower EF, ischemic etiology and cerebral vascular disease.
